Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy

Clinical Nephrology

Volumn 78, Issue 6, 2012, Pages 465-469

  Eison, T Matthew ^a   Hastings, M Colleen ^a   Moldoveanu, Zina ^b   Sanders, John T ^c   Gaber, Lillian ^d   Walker, Patrick D ^e   Lau, Keith K ^f   Julian, Bruce A ^b   Novak, Jan ^b   Wyatt, Robert J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Sanford Children's Hospital   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e Nephropathology Associates   (United States)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Galactose deficient IgA1; Glomerular disease; Glomerulonephritis; IgA nephropathy

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; GALACTOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; MALE; MESANGIUM CELL; MICROSCOPY; SCHOOL CHILD;

EID: 84871557632     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107423     Document Type: Article

References (20)

1. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009; 119: 1668-1677. PubMed
2. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011; 22: 1795-1803. PubMed
3. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999; 104: 73-81. PubMed
4. Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol. 2007; 22: 2067-2072. PubMed
5. Haas M. IgA nephropathy and Henoch-Schönlein purpura nephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney, 6th edition. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 423-486.
6. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007; 71: 1148-1154. PubMed
7. A multicenter study of IgA nephropathy in children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int. 1982; 22: 643-652. PubMed
8. Hattori S, Karashima S, Furuse A, Terashima T, Hiramatsu M, Murakami M, Matsuda I. Clinicopathological correlation of IgA nephropathy in children. Am J Nephrol. 1985; 5: 182-189. PubMed
9. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76: 534-545. PubMed
10. Kher KK, Makker SP, Moorthy B. IgA nephropathy (Berger's disease) - a clinicopathologic study in children. Int J Pediatr Nephrol. 1983; 4: 11-18. PubMed
11. Kim PK, Mong FC, Lee JS, Jeong HJ, Choi IJ. Clinicopathological correlation in forty-two children with IgA nephropathy. Child Nephrol Urol. 1988-1989; 9: 21-28. PubMed
12. Lévy M, Gonzalez-Burchard G, Broyer M, Dommergues JP, Foulard M, Sorez JP, Habib R. Berger's disease in children. Natural history and outcome. Medicine (Baltimore). 1985; 64: 157-180. PubMed
13. Michalk D, Waldherr R, Seelig HP, Weber HP, Schärer K. Idiopathic mesangial IgA-glomerulonephritis in childhood Description of 19 pediatric cases and review of the literature. Eur J Pediatr. 1980; 134: 13-22. PubMed
14. Mina SN, Murphy WM. IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol. 1985; 83: 669-675. PubMed
15. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y. IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol. 1990; 10: 191-197. PubMed
16. Yoshikawa N, Ito H, Nakamura H. IgA nephropathy in children from Japan. Clinical and pathological features. Child Nephrol Urol. 1988-1989; 9: 191-199. PubMed
17. Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010; 77: 921-927. PubMed
18. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis. 1998; 31: 962-970. PubMed
19. Bellur SS, Troyanov S, Cook HT, Roberts IS; Working Group of International IgA Nephropathy Network and Renal Pathology Society. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 2011; 26: 2533-2536. PubMed
20. Levinsky RJ, Barratt TM. IgA immune complexes in Henoch-Schönlein purpura. Lancet. 1979; 2: 1100-1103. PubMed